Suppression of native defense mechanisms, SIRT1 and PPARγ, by dietary glycoxidants precedes disease in adult humans; relevance to lifestyle-engendered chronic diseases

[1]  G. Striker,et al.  Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1 , 2012, Proceedings of the National Academy of Sciences.

[2]  M. Sano,et al.  Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individuals , 2011, Mechanisms of Ageing and Development.

[3]  G. Striker,et al.  Restriction of Advanced Glycation End Products Improves Insulin Resistance in Human Type 2 Diabetes , 2011, Diabetes Care.

[4]  L. Guarente.  Sirtuins, Aging, and Medicine , 2011 .

[5]  M. McNutt,et al.  SIRT1 is regulated by a PPARγ–SIRT1 negative feedback loop associated with senescence , 2010, Nucleic acids research.

[6]  Dean P. Jones,et al.  Oxidative stress modulates PPAR gamma in vascular endothelial cells. , 2010, Free radical biology & medicine.

[7]  G. Striker,et al.  Advanced glycation end products in foods and a practical guide to their reduction in the diet. , 2010, Journal of the American Dietetic Association.

[8]  C. Glass,et al.  Macrophages, inflammation, and insulin resistance. , 2010, Annual review of physiology.

[9]  C. Cobelli,et al.  Downregulation of the Longevity-Associated Protein Sirtuin 1 in Insulin Resistance and Metabolic Syndrome: Potential Biochemical Mechanisms , 2010, Diabetes.

[10]  Dean P. Jones,et al.  Oxidative Stress Modulates PPAR γ in Vascular Endothelial Cells , 2010 .

[11]  L. Ferrucci,et al.  Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGE receptor-1. , 2009, The Journal of clinical endocrinology and metabolism.

[12]  M. Federici,et al.  TIMP3 Is Reduced in Atherosclerotic Plaques From Subjects With Type 2 Diabetes and Increased by SirT1 , 2009, Diabetes.

[13]  Daisuke Koya,et al.  SIRT1 and insulin resistance , 2009, Nature Reviews Endocrinology.

[14]  G. Striker,et al.  Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan. , 2008, The American journal of pathology.

[15]  C. Glass,et al.  Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones. , 2007, The Journal of clinical investigation.

[16]  Lingyun Wu,et al.  Modulation of cardiac and aortic peroxisome proliferator-activated receptor-gamma expression by oxidative stress in chronically glucose-fed rats. , 2006, American journal of hypertension.

[17]  A. Aljada,et al.  Contemporary Reviews in Cardiovascular Medicine Metabolic Syndrome A Comprehensive Perspective Based on Interactions Between Obesity, Diabetes, and Inflammation , 2022 .

[18]  J. Uribarri,et al.  Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[19]  M. Peppa,et al.  Fetal or neonatal low-glycotoxin environment prevents autoimmune diabetes in NOD mice. , 2003, Diabetes.

[20]  J. Uribarri,et al.  Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients. , 2003, Journal of the American Society of Nephrology : JASN.

[21]  P. Libby.  Inflammation in atherosclerosis , 2002, Nature.

[22]  Tingjun Hou,et al.  ADME evaluation in drug discovery , 2002, Journal of molecular modeling.

[23]  M. Peppa,et al.  Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[24]  E. Fisher,et al.  Lowering of dietary advanced glycation endproducts (AGE) reduces neointimal formation after arterial injury in genetically hypercholesterolemic mice. , 2002, Atherosclerosis.

[25]  E. Fisher,et al.  Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse. , 2002, Diabetes.

[26]  M. Peppa,et al.  Oxidative Stress-Inducing Carbonyl Compounds From Common Foods: Novel Mediators of Cellular Dysfunction , 2002, Molecular medicine.

[27]  M. Steffes,et al.  Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products , 2002, Diabetes/metabolism research and reviews.

[28]  M. Jaye,et al.  PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway , 2001, Nature Medicine.

[29]  R. Evans,et al.  PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation , 2001, Nature Medicine.

[30]  Sander Kersten,et al.  Roles of PPARs in health and disease , 2000, Nature.

[31]  R. Bucala,et al.  Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.